CONSULTING AGREEMENTConsulting Agreement • August 5th, 2020 • Constellation Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledAugust 5th, 2020 Company Industry JurisdictionThis Consulting Agreement (the “Agreement”), effective as June 22, 2020 (the “Effective Date”) is made between Constellation Pharmaceuticals, Inc., a Delaware corporation, with offices at 215 First St., Suite 200, Cambridge, MA 02142 (“Constellation”), and Oncology Drug Development, LLC., a Pennsylvania company (“Consultant”) (each a “Party” and collectively the “Parties”).